Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity.
Gamboa Vargas J, Wagner J, Shaikh H, Lang I, Medler J, Anany M, Steinfatt T, Peña Mosca J, Haack S, Dahlhoff J, Büttner-Herold M, Graf C, Viera EA, Einsele H, Wajant H, Beilhack A. Gamboa Vargas J, et al. Among authors: lang i. Front Immunol. 2023 Dec 18;14:1352525. doi: 10.3389/fimmu.2023.1352525. eCollection 2023. Front Immunol. 2023. PMID: 38164131 Free PMC article.
Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1.
Chopra M, Lang I, Salzmann S, Pachel C, Kraus S, Bäuerlein CA, Brede C, Garrote AL, Mattenheimer K, Ritz M, Schwinn S, Graf C, Schäfer V, Frantz S, Einsele H, Wajant H, Beilhack A. Chopra M, et al. Among authors: lang i. PLoS One. 2013 Sep 30;8(9):e75737. doi: 10.1371/journal.pone.0075737. eCollection 2013. PLoS One. 2013. PMID: 24098720 Free PMC article.
TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK.
Carmona Arana JA, Seher A, Neumann M, Lang I, Siegmund D, Wajant H. Carmona Arana JA, et al. Among authors: lang i. Front Immunol. 2014 Feb 18;5:63. doi: 10.3389/fimmu.2014.00063. eCollection 2014. Front Immunol. 2014. PMID: 24600451 Free PMC article.
Targeting of the WT191-138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.
Dagvadorj N, Deuretzbacher A, Weisenberger D, Baumeister E, Trebing J, Lang I, Köchel C, Kapp M, Kapp K, Beilhack A, Hünig T, Einsele H, Wajant H, Grigoleit GU. Dagvadorj N, et al. Among authors: lang i. Cancer Immunol Immunother. 2017 Mar;66(3):319-332. doi: 10.1007/s00262-016-1938-y. Epub 2016 Nov 28. Cancer Immunol Immunother. 2017. PMID: 27896368 Free PMC article.
1,222 results